CardioFocus, Inc., a medical device company dedicated to advancing ablation treatment for cardiac arrythmias, has announced the acquisition of Galvanize Therapeutics’ Electrophysiology Technology division. Notable assets included in the acquisition are the CENTAURI System pulsed electric field generator, which is CE marked and commercially available in the EU and the UK, and the QuickShot™ catheter ablation system, currently in development. CardioFocus now has a complete suite of differentiated and complimentary ablation technologies with the potential to improve clinical outcomes for patients.
Read the full article: CardioFocus Acquires Electrophysiology Division of Galvanize Therapeutics //
Source: https://www.prnewswire.com/news-releases/cardiofocus-acquires-electrophysiology-division-of-galvanize-therapeutics-302031956.html